small-molecule protein degraders

Pathway to discovery in rare disease

Sanofi researchers are investigating a metabolic hub that plays a key role in three classes of rare disease

Covid-19

The Fight against COVID-19

As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients

woman writing on a transparent wall

Supporting People with Cancer during COVID-19

Despite the challenges caused by COVID-19, Sanofi continues to support the patient communities it serves—including the cancer community

Third quarter 2020 results

Third Quarter Results 2020

Sanofi’s financial results will be published on October 29, providing a look at its business performance and the execution of its strategy

  • Camera
    Press releases
    2020-10-26MMMM DD YYYY
    Dupixent® (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK